Alexander Nolte's Insider Trades & SAST Disclosures

Alexander Nolte's most recent trade in Syndax Pharmaceuticals Inc was a trade of 17,000 Stock Options (Right to buy) done . Disclosure was reported to the exchange on Feb. 2, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Syndax Pharmaceuticals Inc
Alexander Nolte Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 17,000 17,000 - - Stock Options (Right to buy)
Syndax Pharmaceuticals Inc
Alexander Nolte Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 30,000 30,000 - - Stock Options (Right to buy)
Syndax Pharmaceuticals Inc
Alexander Nolte Chief Accounting Officer Other type of transaction at price $ 12.39 per share. 01 Feb 2022 968 968 (0%) 0% 12.4 11,994 Common Stock
Syndax Pharmaceuticals Inc
Alexander Nolte Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 16.65 per share. 01 Feb 2022 968 0 (0%) 0% 16.6 16,117 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades